What Is the MAO-A Gene and Why Is It Called the Warrior Gene?

The MAO-A gene provides instructions for making monoamine oxidase A, an enzyme that breaks down key brain chemicals like serotonin, norepinephrine, and dopamine after they have done their signaling work. It earned the nickname “warrior gene” in 2006 after a geneticist publicly linked a common variant found in Māori men to aggression, criminality, and risk-taking. The label stuck in popular culture even though the underlying science is far more complicated, and far less dramatic, than the name suggests.

What the MAO-A Enzyme Actually Does

Think of serotonin, norepinephrine, and dopamine as messengers that carry signals between nerve cells. Once they deliver a message, they need to be cleared away so the next signal can come through cleanly. MAO-A is one of the main cleanup enzymes for that job. It chemically dismantles these neurotransmitters so they do not keep stimulating the receiving cell.¹ When MAO-A activity is low or absent, those neurotransmitters accumulate. Serotonin in particular seems to play a pivotal role during brain development: in mice engineered to lack the MAO-A enzyme entirely, serotonin levels in the brain climbed to roughly nine times normal, and the animals showed structural changes in the sensory cortex along with heightened aggression in adult males.²

There is a close relative called MAO-B that handles some of the same neurotransmitters but with different preferences and in different brain regions. The distinction matters: mice missing only MAO-B did not show the aggressive behavior seen in MAO-A knockouts, suggesting that MAO-A is specifically important for whatever brain chemistry connects to aggression.³

The Low-Activity and High-Activity Variants

Everyone has an MAO-A gene. The question is how actively their version of it works. A stretch of the gene’s promoter region contains a repeating sequence that comes in different lengths. The number of repeats influences how much MAO-A enzyme gets produced. Versions with 3 or fewer repeats tend to produce less enzyme and are referred to as “low activity” (sometimes abbreviated MAOA-L). Versions with 3.5, 4, or 5 repeats generally produce more enzyme and are called “high activity” (MAOA-H). A study comparing men with alcohol use disorder to healthy controls found the low-activity 3-repeat allele in about half of the patients but only about a third of controls, with high-activity alleles more common in the control group.⁴

Because the MAO-A gene sits on the X chromosome, the inheritance pattern differs between sexes. Men have one X chromosome, so they carry a single copy: either low activity or high activity. Women have two X chromosomes, so they can be homozygous for one version or heterozygous, which complicates the picture. Most of the research on behavioral outcomes has been conducted in men, and the gene-environment findings discussed below are strongest in male samples.

Where the “Warrior Gene” Name Came From

The label traces to a specific event. In 2006, a New Zealand geneticist announced findings linking the MAO-A gene to antisocial behaviors in the Māori population, framing it as evidence of a “warrior gene.”⁵ The claimed behaviors included criminality, violence, gambling, and alcoholism.⁶ The announcement provoked fierce backlash from Māori communities, ethicists, and other geneticists. Critics argued it was a textbook case of genetic determinism: taking a gene variant that is common in many populations around the world and using it to explain complex social problems in one ethnic group.

A later study that genotyped Māori individuals did find a reduced genetic diversity at the MAO-A gene locus and an increased frequency of the most common variant, consistent with the repeated population bottlenecks that occurred as Polynesian ancestors island-hopped across the Pacific.⁷ But a reduced diversity pattern shaped by founder effects tells you about demographic history, not about whether any particular variant causes violence. The controversy became a case study in how genetic findings can be misrepresented and weaponized against marginalized communities.⁸

The Gene-Environment Interaction That Started It All

The scientific story that made MAO-A famous predates the Māori controversy by several years. In 2002, a landmark study followed a birth cohort and found that children who were maltreated and who also carried the low-activity MAO-A variant were significantly more likely to develop antisocial behavior as adults. Children with the same maltreatment history but the high-activity variant were substantially less likely to develop those problems.⁹ The gene alone did not predict antisocial outcomes, and childhood maltreatment alone had a weaker effect in carriers of the high-activity variant. It was the combination that mattered.

This gene-environment interaction has been scrutinized extensively since then. A meta-analysis drawing on male cohorts found that childhood maltreatment predicted antisocial outcomes more strongly for men with the low-activity genotype, and the finding was robust to multiple sensitivity checks.¹⁰ A separate 30-year longitudinal study also confirmed the pattern: people with the low-activity variant who had been exposed to childhood abuse were significantly more likely to report offending, conduct problems, and hostility decades later, even after adjusting for other factors.¹¹ Two independent meta-analyses confirmed the original pattern.¹²

The finding is real, but it is critical to understand what it does and does not say. It does not say that people with the low-activity variant are destined to be violent. It says that among people who experienced severe early-life adversity, the low-activity variant is associated with a higher risk of antisocial outcomes. Without the environmental trigger, the genetic variant on its own carries little predictive power.

What Brain Imaging Shows

Researchers have used brain scans to look for differences between carriers of the low- and high-activity variants. The low-activity allele has been linked to altered information processing in a circuit connecting the amygdala (the brain’s threat-detection center), the anterior cingulate, and the medial prefrontal cortex (a region involved in impulse control and decision-making).¹³ When serotonin availability was experimentally lowered in study participants, carriers of the low-activity variant showed a larger disruption of the connection between the amygdala and the prefrontal cortex, while high-activity carriers were more resilient to the same manipulation.¹⁴

In violent offenders diagnosed with antisocial personality disorder and high psychopathic traits, the low-activity genotype was associated with differences in amygdala surface area, specifically in the basolateral nucleus, compared with healthy people carrying the same genotype.¹⁵ This is a finding in a small, extreme clinical population, so it should not be generalized to everyone who carries the low-activity variant. But it does suggest that the gene may interact with other risk factors to shape brain structure in measurable ways.

Beyond Childhood Trauma: Provocation and Testosterone

The gene-environment story is not limited to childhood maltreatment. In a lab experiment that measured aggression in response to escalating provocation, people with the low-activity variant became aggressive more quickly and more intensely as provocation increased, while those with the high-activity variant showed less of that escalation.¹⁶ The effect was largely absent under low provocation, surfacing mainly when subjects were pushed harder. The pattern echoes the childhood-maltreatment findings: the genetic variant seems to matter most when paired with an environmental stressor.

Testosterone adds another layer. A study measuring testosterone in cerebrospinal fluid found that MAO-A genotype and testosterone levels interact to predict antisocial behavior, rather than either factor acting alone.¹⁷ When testosterone was administered experimentally, carriers of the low-activity variant showed less automatic harm avoidance and more risk-taking, accompanied by changes in brain activation during provocative scenarios.¹⁸ This finding is consistent with the broader theme: MAO-A genotype modifies how the brain responds to other biological and environmental inputs, rather than directly “causing” any behavior.

When MAO-A Is Completely Missing: Brunner Syndrome

The most extreme version of the MAO-A story involves Brunner syndrome, a rare genetic disorder caused by mutations that knock out MAO-A function entirely. First described in a Dutch family in the early 1990s, the condition was originally associated with intellectual disability and impulsive aggression. Since then, the clinical picture has broadened. A recent case report documented a child with a novel MAO-A variant who was diagnosed with attention deficit hyperactivity disorder, developmental coordination disorder, and articulation disorder, not the stereotypical aggressive profile.¹⁹ Fewer than two dozen distinct MAO-A gene mutations have been reported for this condition. Brunner syndrome is important for understanding MAO-A biology, but it is vanishingly rare and should not be confused with the common low-activity variant that most “warrior gene” discussions refer to.

Epigenetics and Why the Same Gene Can Behave Differently

Your DNA sequence is not the whole story. Chemical tags called methyl groups can attach to the promoter region of a gene and dial its activity up or down without changing the underlying code. Research in twins found that methylation at sites in the MAO-A gene was associated with depressive symptoms: specifically, lower methylation (hypomethylation) of the MAO-A promoter was linked to more depression.²⁰ Animal research has shown that early-life stress can change MAO-A methylation patterns differently in different brain regions, and that those regional changes correlate with aggressive behavior.²¹

Epigenetics helps explain why two people with the same MAO-A genotype can have very different outcomes. One may go through childhood adversity that alters how much enzyme the gene actually produces, while another with the same variant but a different life history may have perfectly typical MAO-A expression. It is yet another reason why reading a genotype result in isolation tells you very little about a person.

MAO-A in the Courtroom

Defense attorneys have tried to use MAO-A genotyping as evidence in criminal cases, arguing that a defendant’s low-activity variant predisposed them to violence. In the United States, behavioral genetic evidence involving MAO-A has appeared almost exclusively in capital murder cases and has been used as a mitigating factor at sentencing rather than as a defense against guilt. No judge has accepted genetic evidence to exculpate a defendant from legal responsibility.²² In a review of cases where genotype evidence was introduced during sentencing, it was admitted in most cases but resulted in a lesser sentence in only one.²³

Courts have sometimes gone the other direction entirely. In a New Mexico murder case, the state supreme court unanimously upheld a trial judge’s decision to exclude behavioral genetic evidence about the defendant’s low-activity MAO-A variant, even though the defense argued it had predisposed the defendant to violent behavior in combination with childhood maltreatment.²⁴ The legal landscape remains unsettled, but the trend is clear: courts treat MAO-A evidence with substantial skepticism, and the science supports that caution.

Why “Warrior Gene” Is a Misleading Name

The nickname implies a straightforward causal chain: carry this variant, become a warrior. The evidence does not support that framing in any version. First, the low-activity variant is extremely common. Depending on the population studied, roughly a third to over half of men carry some form of it. If it were a reliable predictor of aggression, a huge proportion of the male population would be consistently violent, and they are not. Second, the behavioral effects that have been documented are context-dependent: they emerge primarily when the genetic variant combines with childhood maltreatment, acute provocation, or hormonal shifts. Third, the overall contribution of genetics to aggression is modest. A large study using polygenic scores found that a composite genetic score for aggression accounted for about 0.2% of the variation in aggressive behavior across a sample of over thirteen thousand individuals, a real but tiny fraction.²⁵ No single gene comes close to “explaining” aggression.

The label also carries racial and ethnic undertones. Singling out any ethnic group as having a “warrior gene” reduces centuries of complex history, structural inequality, and cultural context to a molecular sequence. The 2006 Māori controversy illustrated the real harm this kind of framing can do, reinforcing stereotypes and feeding the false idea that genes determine behavior in a simple, direct way.

MAO-A During Brain Development

Some of the most striking effects of MAO-A activity occur during fetal and early postnatal brain development, not in the adult brain. When MAO-A function is disrupted during these windows, serotonin accumulates and appears to suppress the proliferation of certain neural stem cells in the developing brain. In mice lacking MAO-A, researchers found that this serotonin-driven suppression began late in embryonic development and persisted into adulthood. Blocking serotonin production during a critical embryonic window restored normal stem cell numbers, confirming that serotonin was the mediator.²⁶

This developmental angle is relevant beyond genetics. Cigarette smoke is a known inhibitor of MAO enzymes. One hypothesis is that maternal smoking during pregnancy may effectively mimic what happens in MAO-A-deficient mice: suppressing the enzyme during fetal development, allowing serotonin to accumulate in the fetal brain, and increasing the risk of behavioral problems like irritability, poor self-control, and aggression in the child. The risk is thought to be compounded if the child also carries a low-activity MAO-A variant.²⁷ Mice engineered to lack MAO-A showed not only aggression but also repetitive and antisocial-like behaviors reminiscent of autism spectrum features.²⁸

MAO-A and Medications You Might Recognize

If MAO-A sounds vaguely familiar outside the “warrior gene” context, it may be because of MAO inhibitors, a class of psychiatric medications that have been prescribed for decades to treat depression and anxiety. These drugs work by blocking the MAO enzyme so that serotonin, norepinephrine, and dopamine linger longer in the brain, boosting mood. The downside is that blocking MAO-A also disables the body’s ability to handle tyramine, a compound found in aged cheeses, cured meats, and fermented foods. Without MAO-A to break tyramine down, it can trigger dangerous spikes in blood pressure, sometimes with as little as eight to ten milligrams of dietary tyramine.²⁹ The strict dietary rules that come with older MAO inhibitors are one reason these drugs fell out of favor once newer antidepressants arrived, though they remain an important option for treatment-resistant cases.

Signs of Natural Selection

Researchers have found evidence that the MAO-A gene region underwent positive natural selection in human history. A study comparing genetic diversity patterns found signs of a selective sweep, where a beneficial variant spreads through a population fast enough to reduce variation in the surrounding DNA. Different versions of the gene appear to have become fixed in different populations, which is consistent with local adaptation to different environmental pressures.³⁰ Evidence for selection has been detected across multiple ethnic groups spanning different continents. What was being selected for remains unclear. The variants in question could have offered advantages related to stress tolerance, risk assessment, or entirely unrelated functions of serotonin and norepinephrine. “Warrior” is one dramatic interpretation; metabolic efficiency or disease resistance are equally plausible, and more parsimonious, alternatives.